Loading…
Chinese maker of test-and-measurement instruments, notably oscilloscopes, spectrum and signal analyzers.
Chinese maker of test-and-measurement instruments, notably oscilloscopes, spectrum and signal analyzers.
Sells instruments through distributors worldwide, with a large share of sales overseas, mostly priced below the established test-equipment makers, with the cost edge of Chinese engineering and manufacturing. Revenue follows electronics R&D and education budgets as well as production-line spending.
In one line: A China-based Keysight/Rigol peer.
Moat: narrow (brand, distribution). Established global brand among engineers and hobbyists competing on price/performance.
Headquarters: Shenzhen, China · Employees: 577
Size Siglent Technologies (688112.SS) is a China Industrials company (Miscellaneous Commercial Services) with a market value of $1.41B, the 1732nd largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥58.53 on 6 Nov 2026.
Performance Over six months the shares fell 5.0%, against -7.7% for the median peer and -16.4% for the China market (cap-weighted) — 10th highest of 21 in its peer set.
Growth Revenue grew 29.5% over the last twelve months (peer median +6.3%); the operating margin is 24.1% (peer median 7.2%).
Valuation It trades at 46.2× forward earnings against a peer median of 14.8× (3rd most expensive of 15).
Price implies For today's price to make sense, revenue must grow about 31% a year for seven years (Req g). Recent delivered growth is +22%, so the hurdle is +9 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 21.8 points above its cost of capital (10.7% WACC).
Next results Next results expected around 29 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥744M | CN¥598M | CN¥495M | CN¥480M | CN¥396M |
| Revenue growth | — | +21% | +3% | +21% | — |
| Gross profit | CN¥473M | CN¥351M | CN¥291M | CN¥286M | CN¥224M |
| EBITDA | n/a | CN¥135M | CN¥98.5M | CN¥126M | CN¥100M |
| Net income | CN¥185M | CN¥143M | CN¥112M | CN¥155M | CN¥141M |
| Free cash flow | CN¥109M | CN¥152M | CN¥83.8M | CN¥86.5M | CN¥13.3M |
| Capital expenditure | CN¥30.9M | CN¥28.7M | CN¥34.3M | CN¥21.2M | CN¥16.4M |
| Total debt | CN¥30.5M | CN¥36.5M | CN¥44.3M | CN¥15.0M | CN¥21.5M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 688112.SS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -36.2% | -6.4% | lowest of 21 |
| 6-month return | -5.0% | -7.7% | 10th highest of 21 |
| Distance from 52-week high | -52.0% | -36.5% | 3rd lowest of 21 |
| Revenue growth (TTM) | +29.5% | +6.3% | 2nd highest of 21 |
| Operating margin | 24.1% | 7.2% | 3rd highest of 21 |
| Forward P/E | 46.2× | 14.8× | 3rd most expensive of 15 |
| Growth the price implies (Req g, 7 yrs) | 31.3% | 4.0% | 3rd most demanding of 14 |
| Growth delivered (Del g) | +22.0% | +6.7% | 2nd highest of 14 |
| Hurdle (Req g minus delivered) | +9.3 pp | -9.0 pp | 3rd most demanding of 14 |
| ROIC minus cost of capital | +21.8 pp | -3.8 pp | 2nd highest of 20 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Siglent Technologies 688112.SS | China | $1.41B | -5% | +30% | 24% | 46.2× | 31.3% | +22.0% |
| Concord Biotech CONCORDBIO.NS | India | $1.40B | +2% | +4% | 28% | 38.2× | 47.1% | +11.6% |
| China National Electric Apparatus Research Institute 688128.SS | China | $1.42B | -12% | +8% | 11% | 15.5× | 4.0% | +13.5% |
| Derichebourg DBG.PA | France | $1.42B | -24% | -3% | 5% | 8.9× | 6.8% | +6.3% |
| Wintech Nano (Suzhou) 688757.SS | China | $1.39B | -18% | +23% | 7% | n/a | n/a | n/a |
| China Security 600654.SS | China | $1.39B | -31% | -30% | -1% | n/a | 56.7% | +0.4% |
| ICF International ICFI | United States | $1.43B | +14% | -8% | 8% | 10.8× | -2.2% | +4.4% |
| SBS 2384.T | Japan | $1.38B | +32% | +22% | 6% | 14.1× | -8.2% | +13.8% |
| Suzhou Recodeal Interconnect System 688800.SS | China | $1.47B | -55% | +5% | 9% | 28.7× | 26.1% | +38.9% |
| Changchun Up Optotech 002338.SZ | China | $1.34B | -39% | +22% | 2% | 43.4× | n/a | n/a |
| Shanghai Medicilon 688202.SS | China | $1.47B | +18% | +42% | -2% | 91.8× | n/a | n/a |
| Taiwan Secom 9917.TW | Taiwan | $1.47B | -8% | +3% | 16% | 14.2× | -2.3% | +6.7% |
| TKC 9746.T | Japan | $1.34B | +21% | +14% | 22% | 18.1× | -9.9% | +4.2% |
| Nittetsu Mining 1515.T | Japan | $1.34B | +10% | +13% | 9% | n/a | n/a | n/a |
| Central Mine Planning & Design Institute CMPDI.NS | India | $1.34B | -15% | +10% | 33% | n/a | 4.0% | +18.7% |
| Shenzhen Ampron Technology 301413.SZ | China | $1.48B | -7% | +11% | 2% | 423.6× | n/a | n/a |
| Shanghai Foreign Service 600662.SS | China | $1.49B | -14% | +1% | 2% | 13.8× | -20.6% | +1.9% |
| Suzhou Novoprotein Scientific 688137.SS | China | $1.33B | +161% | +8% | -62% | n/a | n/a | n/a |
| Clarivate CLVT | United States | $1.50B | -16% | -9% | 8% | 3.8× | 13.4% | +14.4% |
| Foxtron Vehicle Technologies 2258.TW | Taiwan | $1.50B | +1% | -50% | -132% | n/a | n/a | n/a |
| AFRY AFRY.ST | Sweden | $1.50B | +17% | -4% | 7% | 12.7× | -2.2% | +6.3% |